Mineralocorticoid Receptor Antagonists and Cardiovascular Health with Kidney Failure

被引:1
作者
Soomro, Qandeel H. [1 ]
Charytan, David M. [1 ]
机构
[1] NYU, Dept Med, Div Nephrol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 16卷 / 06期
关键词
cardiovascular disease; hemodialysis; mineralocorticoid receptor antagonists; kidney failure; heart failure; ALDOSTERONE; SPIRONOLACTONE; DYSFUNCTION;
D O I
10.2215/CJN.04460421
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:843 / 845
页数:3
相关论文
共 11 条
  • [11] Spironolactone Attenuates Experimental Uremic Cardiomyopathy by Antagonizing Marinobufagenin
    Tian, Jiang
    Shidyak, Amjad
    Periyasamy, Sankaridrug M.
    Haller, Steven
    Taleb, Mohamed
    El-Okdi, Nasser
    Elkareh, Jihad
    Gupta, Shalini
    Gohara, Sabry
    Fedorova, Olga V.
    Cooper, Christopher J.
    Xie, Zijian
    Malhotra, Deepak
    Bagrov, Alexei Y.
    Shapiro, Joseph I.
    [J]. HYPERTENSION, 2009, 54 (06) : 1313 - +